meglumine antimoniate has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, IH; Ben Abdallah, N; Ben Maïz, H; Ben Moussa, F; Ben Salem, L; Cherif, L; el Younsi, F; Khiari, K; Maazoun, I; Turki, S | 1 |
| Atabek, ME; Pirgon, O; Unal, E | 1 |
2 other study(ies) available for meglumine antimoniate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
[Obstructive acute renal failure revealing visceral leishmaniasis in a diabetic patient].
Topics: Acute Kidney Injury; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Diabetes Mellitus, Type 1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed | 2003 |
Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes.
Topics: Adolescent; Antimony; Antiprotozoal Agents; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Knee; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2006 |